tirzepatide heart attack SUMMIT: Improves Outcomes and Quality of Life For Patients With HFpEF and Obesity Tirzepatide for Heart Failure in

These slices were stained with hematoxylin and eosin, focusing on the lateral portion of the femoral condyle

Primary target: It binds to amylin and calcitonin receptors, helping regulate food intake and satiety at the brain level while also influencing digestion

Talk to your doctor about what is right for you Time savings: Maintenance medications are those drugs you take on a regular basis

Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists